Correction to: Natural compound Oblongifolin C confers gemcitabine resistance in pancreatic cancer by downregulating Src/MAPK/ERK pathways

Correction to: Natural compound Oblongifolin C confers gemcitabine resistance in pancreatic cancer by downregulating Src/MAPK/ERK pathways

Saved in:

Bibliographic Details
Main Authors:	Yang Li, Zhichao Xi, Xiaoqiong Chen, Shuangfan Cai, Chen Liang, Zhen Wang, Yingyi Li, Hongsheng Tan, Yuanzhi Lao, Hongxi Xu
Format:	Article
Language:	English
Published:	Nature Publishing Group 2025-04-01
Series:	Cell Death and Disease
Online Access:	https://doi.org/10.1038/s41419-025-07495-2
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Magnoliae flos Downregulated Lipopolysaccharide-Induced Inflammatory Responses via NF-κB/ERK-JNK MAPK/STAT3 Pathways
by: Tae-Young Gil, et al.
Published: (2022-01-01)

MAPK/ERK signaling pathway in rheumatoid arthritis: mechanisms and therapeutic potential
by: Jun Xie, et al.
Published: (2025-07-01)

Indirubin attenuates sepsis by targeting the EGFR/SRC/PI3K and NF-κB/MAPK signaling pathways in macrophages
by: Yancen Li, et al.
Published: (2025-03-01)

Siglec6 CAR T cells suppressed progression of AML via inhibiting Siglec6 and SHP2 induced Src and ERK signaling activation
by: Qian Li, et al.
Published: (2025-05-01)

SPAG6 Promotes Multiple Myeloma Through Activation of the MAPK/ERK Signaling Pathway
by: Junnan Li, et al.
Published: (2025-06-01)

Oncogenic mutant RAS signaling activity is rescaled by the ERK/MAPK pathway
by: Taryn E Gillies, et al.
Published: (2020-10-01)

Association of phosphorylation status of ERK and genetic MAPK alterations in pediatric tumors
by: Florian Selt, et al.
Published: (2025-04-01)

Inotodiol induces hepatocellular carcinoma apoptosis by activation of MAPK/ERK pathway.
by: Yushuang Xing, et al.
Published: (2025-01-01)

Temporal perturbation of ERK dynamics reveals network architecture of FGF2/MAPK signaling
by: Yannick Blum, et al.
Published: (2019-11-01)

MUC3A promotes the progression of cholangiocarcinoma through the MAPK/ERK pathway
by: Baijie Feng, et al.
Published: (2025-04-01)

EIF3B affects the invasion and metastasis of hepatocellular carcinoma cells via the TGFBI/MAPK/ERK pathway
by: Ling Wang, et al.
Published: (2025-01-01)

Heterozygous deletion of exon 17 of the Kit gene impairs mouse spermatogenesis by attenuating MAPK-ERK signaling
by: Siyuan Lin, et al.
Published: (2025-05-01)

A viral protein activates the MAPK pathway to promote viral infection by downregulating callose deposition in plants
by: Lixiao Feng, et al.
Published: (2024-12-01)

Cbl-b inhibitor NX-1607 activates MAPK/ERK signaling pathway and enhances T-cell activation
by: Ting Yu, et al.
Published: (2025-05-01)

RAB26 promotes prostate cancer progression via the MAPK/ERK-TWIST1 signaling axis
by: Hexi Wang, et al.
Published: (2025-11-01)

6-Gingerol, an active compound of ginger, attenuates NASH-HCC progression by reprogramming tumor-associated macrophage via the NOX2/Src/MAPK signaling pathway
by: Qiurui Li, et al.
Published: (2025-04-01)

Sulforaphane attenuates aldose reductase-mediated platelet dysfunction in high glucose-stimulated human platelets via downregulation of the Src/ROS/p53 signaling pathway
by: Xiaoyan Bi, et al.
Published: (2025-08-01)

PGRP-S promotes hepatocellular carcinoma progression via MAPK/ERK pathway by interaction with TTC1
by: Huifang Zhu, et al.
Published: (2025-08-01)

Alpha-enolase promotes progression of acute myeloid leukemia via MAPK/ERK signaling pathway
by: Shanshan Zhang, et al.
Published: (2025-09-01)

MAPK ERK signaling regulates the TGF-beta1-dependent mosquito response to Plasmodium falciparum.
by: Win Surachetpong, et al.
Published: (2009-04-01)

Reciprocal regulation of Solo and Src orchestrates Src trafficking to promote mesenchymal cell migration
by: Florian Meyer, et al.
Published: (2025-06-01)

PPP2CB aggravates atherosclerosis-related dyslipidemia via LOX-1/MAPK/ERK signaling pathway
by: He An, et al.
Published: (2025-07-01)

Peptide CCAT1-70aa promotes hepatocellular carcinoma proliferation and invasion via the MAPK/ERK pathway
by: Wu Xianjian, et al.
Published: (2025-08-01)

Fucosterol exerts an anti-atherosclerotic action via NF-κB and p38/Erk MAPK signaling pathways
by: Tiancheng Liu, et al.
Published: (2025-06-01)

Polystyrene nanoplastics exposure induces cognitive impairment in mice via induction of oxidative stress and ERK/MAPK-mediated neuronal cuproptosis
by: Yinuo Chen, et al.
Published: (2025-05-01)

Sprouty4 negatively regulates ERK/MAPK signaling and the transition from in situ to invasive breast ductal carcinoma.
by: Ethan J Brock, et al.
Published: (2021-01-01)

Eplerenone Inhibits Atrial Autonomic Nerve Remodeling in Atrial Fibrillation Through ERK1/2 MAPK Pathway
by: Wei Xu, et al.
Published: (2025-01-01)

Rosavin exerts an antitumor role and inactivates the MAPK/ERK pathway in small-cell lung carcinoma in vitro
by: Liu Rui, et al.
Published: (2023-06-01)

L-741626 inhibits hepatocellular carcinoma progression by targeting Ref-1 to suppress MAPK/ERK signalling pathway activity
by: Shuiling Jin, et al.
Published: (2025-04-01)

Hypoxia Activates FGF-23-ERK/MAPK Signaling Pathway in Ischemia-Reperfusion-Induced Acute Kidney Injury
by: Weihua Liu, et al.
Published: (2024-10-01)

CD5L induces inflammation and survival in RA-FLS through ERK1/2 MAPK pathway
by: Huiqing Yang, et al.
Published: (2024-12-01)

MiR‐766‐3p Inhibit the Proliferation, Stemness, and Cell Cycle of Pancreatic Cancer Cells Through the MAPK/ERK Signaling Pathway
by: Zhipeng Quan, et al.
Published: (2024-12-01)

YWHAG promotes bladder cancer metastasis by regulating TMOD3 to activate ERK1/2 and JNK phosphorylation in the MAPK pathway
by: Tai Tian, et al.
Published: (2024-12-01)

Role of Oral Bacteria in Mediating Gemcitabine Resistance in Pancreatic Cancer
by: Geng Xu, et al.
Published: (2025-07-01)

ADAM17 selectively activates the IL‐6 trans‐signaling/ERK MAPK axis in KRAS‐addicted lung cancer
by: Mohamed I Saad, et al.
Published: (2019-03-01)

Xuesanqi ameliorates DSS-induced colitis in mice by mediating gut microbiota dysbiosis and modulating MAPK/ERK/JNK pathway
by: Qiyuan Su, et al.
Published: (2024-12-01)

Establishment of in vitro Src tyrosine kinase inhibitors screening model
by: WANG Chen-hui, et al.
Published: (2007-11-01)

Downregulation of ROR2 attenuates LPS‐induced A549 cell injury through JNK and ERK signaling pathways
by: Zhonglin Wang, et al.
Published: (2023-04-01)

Sialylated IgG-activated integrin β4-Src-Erk axis stabilizes c-Myc in a p300 lysine acetyltransferase-dependent manner to promote colorectal cancer liver metastasis
by: Jing Chen, et al.
Published: (2025-03-01)

WWOX rs11644322 polymorphism, gemcitabine, and pancreatic cancer
by: Sora Yasri, et al.
Published: (2017-01-01)